Hinge Health Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗服务供应商行业排名27/77位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价63.93。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Hinge Health Inc评分
相关信息
行业排名
27 / 77
全市场排名
140 / 4562
所属行业
医疗服务供应商
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Hinge Health Inc亮点
亮点风险
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
公司代码HNGE
公司Hinge Health Inc
CEOPerez (Daniel Antonio)
网址https://en-gb.hingehealth.com/
常见问题
Hinge Health Inc(HNGE)的当前股价是多少?
Hinge Health Inc(HNGE)的当前股价是 47.920。
Hinge Health Inc的股票代码是什么?
Hinge Health Inc的股票代码是HNGE。
Hinge Health Inc股票的52周最高点是多少?
Hinge Health Inc股票的52周最高点是62.180。
Hinge Health Inc股票的52周最低点是多少?
Hinge Health Inc股票的52周最低点是33.423。
Hinge Health Inc的市值是多少?
Hinge Health Inc的市值是3.77B。
Hinge Health Inc的净利润是多少?
Hinge Health Inc的净利润为-11.93M。
现在Hinge Health Inc(HNGE)的股票是买入、持有还是卖出?
根据分析师评级,Hinge Health Inc(HNGE)的总体评级为买入,目标价格为63.929。